Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence

Condition:   Esophageal Malignant Neoplasm, Local Recurrence Interventions:   Drug: Procedural death 1;   Drug: Capecitabine;   Radiation: Radiotherapy;   Drug: Placebo Sponsor:   The First Affiliated Hospital of Henan University of Science and Technology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials